Medtronic (MDT) Current Deferred Revenue (2025 - 2026)
Medtronic's (MDT) quarterly Current Deferred Revenue came in at $237.0 million in Q3 2026, down 33.24% year-over-year from $355.0 million in Q3 2025, and down 4.82% quarter-over-quarter from $249.0 million in Q2 2026.
Powered by 
Analysis
Medtronic (MDT) Current Deferred Revenue (2025 - 2026) Analysis & Trends
Medtronic has disclosed Current Deferred Revenue across 2 years of filings, most recently posting $237.0 million for Q3 2026.
- In Q3 2026, Current Deferred Revenue fell 33.24% year-over-year to $237.0 million; the TTM figure through Jul 2026 stood at $237.0 million (down 33.24% YoY), while the FY2026 annual figure was $249.0 million, down 36.32% from the prior year.
- Current Deferred Revenue came in at $237.0 million for Q3 2026 at Medtronic, down from $249.0 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $391.0 million in Q2 2025 to a low of $237.0 million in Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 17.73 Bn | 17.32 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 237.00 Mn |
| Apr 24, 2026 | 249.00 Mn |
| Jan 23, 2026 | 283.00 Mn |
| Oct 24, 2025 | 318.00 Mn |
| Jul 25, 2025 | 355.00 Mn |
| Apr 25, 2025 | 391.00 Mn |